(CTRA) Coterra Energy - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US1270971039
Stock:
Total Rating 43
Risk 70
Buy Signal -0.20
| Risk 5d forecast | |
|---|---|
| Volatility | 28.0% |
| Relative Tail Risk | 0.89% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.61 |
| Alpha | 7.58 |
| Character TTM | |
|---|---|
| Beta | 0.488 |
| Beta Downside | 1.305 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.62% |
| CAGR/Max DD | 0.39 |
EPS (Earnings per Share)
Revenue
Description: CTRA Coterra Energy
Coterra Energy Inc., an independent oil and gas company, engages in the exploration, development, and production of oil, natural gas, and natural gas liquids in the United States. The company's properties include the Permian Basin with approximately 2,97,000 net acres in west Texas and southeast, New Mexico; Marcellus Shale properties approximately 1,86,000 net acres located in Susquehanna County, Pennsylvania; and Anadarko Basin with approximately 1,81,000 net acres located in mid-continent region in Oklahoma. It also operates natural gas and saltwater gathering, and disposal systems in Texas. The company sells its natural gas to industrial customers, local distribution companies, oil and gas marketers, energy companies, pipeline companies, and power generation facilities. The company was incorporated in 1989 and is headquartered in Houston, Texas.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 1.65b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 0.45 > 1.0 |
| NWC/Revenue: 0.53% < 20% (prev 11.89%; Δ -11.36% < -1%) |
| CFO/TA 0.15 > 3% & CFO 3.68b > Net Income 1.65b |
| Net Debt (4.02b) to EBITDA (4.42b): 0.91 < 3 |
| Current Ratio: 1.02 > 1.5 & < 3 |
| Outstanding Shares: last quarter (763.0m) vs 12m ago 2.55% < -2% |
| Gross Margin: 36.64% > 18% (prev 0.32%; Δ 3631 % > 0.5%) |
| Asset Turnover: 31.78% > 50% (prev 27.38%; Δ 4.40% > 0%) |
| Interest Coverage Ratio: 12.06 > 6 (EBITDA TTM 4.42b / Interest Expense TTM 185.0m) |
Altman Z'' 2.37
| A: 0.00 (Total Current Assets 1.53b - Total Current Liabilities 1.49b) / Total Assets 24.01b |
| B: 0.28 (Retained Earnings 6.70b / Total Assets 24.01b) |
| C: 0.10 (EBIT TTM 2.23b / Avg Total Assets 22.07b) |
| D: 0.73 (Book Value of Equity 6.79b / Total Liabilities 9.29b) |
| Altman-Z'' Score: 2.37 = BBB |
Beneish M -2.66
| DSRI: 1.71 (Receivables 1.22b/562.0m, Revenue 7.01b/5.51b) |
| GMI: 0.88 (GM 36.64% / 32.38%) |
| AQI: 0.62 (AQ_t 0.01 / AQ_t-1 0.01) |
| SGI: 1.27 (Revenue 7.01b / 5.51b) |
| TATA: -0.08 (NI 1.65b - CFO 3.68b) / TA 24.01b) |
| Beneish M-Score: -2.66 (Cap -4..+1) = A |
What is the price of CTRA shares?
As of March 02, 2026, the stock is trading at USD 30.59 with a total of 8,346,928 shares traded.
Over the past week, the price has changed by -0.52%, over one month by +10.00%, over three months by +13.51% and over the past year by +20.49%.
Over the past week, the price has changed by -0.52%, over one month by +10.00%, over three months by +13.51% and over the past year by +20.49%.
Is CTRA a buy, sell or hold?
Coterra Energy has received a consensus analysts rating of 4.31.
Therefore, it is recommended to buy CTRA.
- StrongBuy: 12
- Buy: 10
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CTRA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 33 | 7.9% |
| Analysts Target Price | 33 | 7.9% |
CTRA Fundamental Data Overview February 27, 2026
P/E Trailing = 13.8426
P/E Forward = 7.3692
P/S = 3.4151
P/B = 1.2137
P/EG = 44.6673
Revenue TTM = 7.01b USD
EBIT TTM = 2.23b USD
EBITDA TTM = 4.42b USD
Long Term Debt = 3.67b USD (from longTermDebt, last quarter)
Short Term Debt = 329.0m USD (from shortTermDebt, last quarter)
Debt = 4.12b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.02b USD (from netDebt column, last quarter)
Enterprise Value = 26.78b USD (22.77b + Debt 4.12b - CCE 98.0m)
Interest Coverage Ratio = 12.06 (Ebit TTM 2.23b / Interest Expense TTM 185.0m)
EV/FCF = 18.50x (Enterprise Value 26.78b / FCF TTM 1.45b)
FCF Yield = 5.41% (FCF TTM 1.45b / Enterprise Value 26.78b)
FCF Margin = 20.65% (FCF TTM 1.45b / Revenue TTM 7.01b)
Net Margin = 23.47% (Net Income TTM 1.65b / Revenue TTM 7.01b)
Gross Margin = 36.64% ((Revenue TTM 7.01b - Cost of Revenue TTM 4.44b) / Revenue TTM)
Gross Margin QoQ = 35.55% (prev 32.08%)
Tobins Q-Ratio = 1.12 (Enterprise Value 26.78b / Total Assets 24.01b)
Interest Expense / Debt = 1.21% (Interest Expense 50.0m / Debt 4.12b)
Taxrate = 23.88% (101.0m / 423.0m)
NOPAT = 1.70b (EBIT 2.23b * (1 - 23.88%))
Current Ratio = 1.02 (Total Current Assets 1.53b / Total Current Liabilities 1.49b)
Debt / Equity = 0.28 (Debt 4.12b / totalStockholderEquity, last quarter 14.72b)
Debt / EBITDA = 0.91 (Net Debt 4.02b / EBITDA 4.42b)
Debt / FCF = 2.78 (Net Debt 4.02b / FCF TTM 1.45b)
Total Stockholder Equity = 14.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.46% (Net Income 1.65b / Total Assets 24.01b)
RoE = 11.63% (Net Income TTM 1.65b / Total Stockholder Equity 14.15b)
RoCE = 12.51% (EBIT 2.23b / Capital Employed (Equity 14.15b + L.T.Debt 3.67b))
RoIC = 9.37% (NOPAT 1.70b / Invested Capital 18.13b)
WACC = 6.67% (E(22.77b)/V(26.88b) * Re(7.71%) + D(4.12b)/V(26.88b) * Rd(1.21%) * (1-Tc(0.24)))
Discount Rate = 7.71% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.58%
[DCF] Terminal Value 82.97% ; FCFF base≈1.32b ; Y1≈1.29b ; Y5≈1.32b
[DCF] Fair Price = 36.16 (EV 31.45b - Net Debt 4.02b = Equity 27.43b / Shares 758.6m; r=6.67% [WACC]; 5y FCF grow -2.75% → 2.90% )
EPS Correlation: -78.03 | EPS CAGR: -55.60% | SUE: -4.0 | # QB: 0
Revenue Correlation: -47.62 | Revenue CAGR: -4.32% | SUE: 0.91 | # QB: 1
EPS next Year (2026-12-31): EPS=2.08 | Chg7d=+0.029 | Chg30d=-0.214 | Revisions Net=-14 | Growth EPS=-3.5% | Growth Revenue=-0.4%
P/E Forward = 7.3692
P/S = 3.4151
P/B = 1.2137
P/EG = 44.6673
Revenue TTM = 7.01b USD
EBIT TTM = 2.23b USD
EBITDA TTM = 4.42b USD
Long Term Debt = 3.67b USD (from longTermDebt, last quarter)
Short Term Debt = 329.0m USD (from shortTermDebt, last quarter)
Debt = 4.12b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.02b USD (from netDebt column, last quarter)
Enterprise Value = 26.78b USD (22.77b + Debt 4.12b - CCE 98.0m)
Interest Coverage Ratio = 12.06 (Ebit TTM 2.23b / Interest Expense TTM 185.0m)
EV/FCF = 18.50x (Enterprise Value 26.78b / FCF TTM 1.45b)
FCF Yield = 5.41% (FCF TTM 1.45b / Enterprise Value 26.78b)
FCF Margin = 20.65% (FCF TTM 1.45b / Revenue TTM 7.01b)
Net Margin = 23.47% (Net Income TTM 1.65b / Revenue TTM 7.01b)
Gross Margin = 36.64% ((Revenue TTM 7.01b - Cost of Revenue TTM 4.44b) / Revenue TTM)
Gross Margin QoQ = 35.55% (prev 32.08%)
Tobins Q-Ratio = 1.12 (Enterprise Value 26.78b / Total Assets 24.01b)
Interest Expense / Debt = 1.21% (Interest Expense 50.0m / Debt 4.12b)
Taxrate = 23.88% (101.0m / 423.0m)
NOPAT = 1.70b (EBIT 2.23b * (1 - 23.88%))
Current Ratio = 1.02 (Total Current Assets 1.53b / Total Current Liabilities 1.49b)
Debt / Equity = 0.28 (Debt 4.12b / totalStockholderEquity, last quarter 14.72b)
Debt / EBITDA = 0.91 (Net Debt 4.02b / EBITDA 4.42b)
Debt / FCF = 2.78 (Net Debt 4.02b / FCF TTM 1.45b)
Total Stockholder Equity = 14.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.46% (Net Income 1.65b / Total Assets 24.01b)
RoE = 11.63% (Net Income TTM 1.65b / Total Stockholder Equity 14.15b)
RoCE = 12.51% (EBIT 2.23b / Capital Employed (Equity 14.15b + L.T.Debt 3.67b))
RoIC = 9.37% (NOPAT 1.70b / Invested Capital 18.13b)
WACC = 6.67% (E(22.77b)/V(26.88b) * Re(7.71%) + D(4.12b)/V(26.88b) * Rd(1.21%) * (1-Tc(0.24)))
Discount Rate = 7.71% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.58%
[DCF] Terminal Value 82.97% ; FCFF base≈1.32b ; Y1≈1.29b ; Y5≈1.32b
[DCF] Fair Price = 36.16 (EV 31.45b - Net Debt 4.02b = Equity 27.43b / Shares 758.6m; r=6.67% [WACC]; 5y FCF grow -2.75% → 2.90% )
EPS Correlation: -78.03 | EPS CAGR: -55.60% | SUE: -4.0 | # QB: 0
Revenue Correlation: -47.62 | Revenue CAGR: -4.32% | SUE: 0.91 | # QB: 1
EPS next Year (2026-12-31): EPS=2.08 | Chg7d=+0.029 | Chg30d=-0.214 | Revisions Net=-14 | Growth EPS=-3.5% | Growth Revenue=-0.4%